Barely Significant
← all excerpts

<i>PBRM1</i> mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer.

NPJ Precis Oncol · 2020 · PMC7075870 · PMID 32195359

Europe PMCDOI
1
hedged sentence
0.0480
closest p · 1.0× alpha
0.0480
boldest claim

The sentences

marginally significantP = 0.048actually significant
In the cohort of non-ICB-treated patients ( N os = 454, PBRM1 MT = 15), there seems to be marginally significant difference in OS between the PBRM1 mutation subgroup and the PBRM1 WT subgroup, with the survival curves overlapped visually ( P = 0.048; Fig. 1b ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.